These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19399292)

  • 1. Bacterial vaginosis: an overview for 2009.
    Livengood CH
    Rev Obstet Gynecol; 2009; 2(1):28-37. PubMed ID: 19399292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tinidazole in the treatment of bacterial vaginosis.
    Armstrong NR; Wilson JD
    Int J Womens Health; 2010 Aug; 1():59-65. PubMed ID: 21072275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin.
    Petrina MAB; Cosentino LA; Rabe LK; Hillier SL
    Anaerobe; 2017 Oct; 47():115-119. PubMed ID: 28522362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gardnerella vaginalis and anaerobic bacteria in the etiology of bacterial (nonspecific) vaginosis.
    Spiegel CA; Davick P; Totten PA; Chen KC; Eschenbach DA; Amsel R; Holmes KK
    Scand J Infect Dis Suppl; 1983; 40():41-6. PubMed ID: 6607521
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Morrill S; Gilbert NM; Lewis AL
    Front Cell Infect Microbiol; 2020; 10():168. PubMed ID: 32391287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of the biotypes of Gardnerella vaginalis.
    Briselden AM; Hillier SL
    J Clin Microbiol; 1990 Dec; 28(12):2761-4. PubMed ID: 2280007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment.
    Verstraelen H; Swidsinski A
    Curr Opin Infect Dis; 2013 Feb; 26(1):86-9. PubMed ID: 23221767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis].
    Tomusiak A; Strus M; Heczko PB
    Ginekol Pol; 2011 Dec; 82(12):900-4. PubMed ID: 22384625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the treatment of bacterial vaginosis: focus on tinidazole.
    Dickey LJ; Nailor MD; Sobel JD
    Ther Clin Risk Manag; 2009 Jun; 5(3):485-9. PubMed ID: 19707258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo.
    Hymes SR; Randis TM; Sun TY; Ratner AJ
    J Infect Dis; 2013 May; 207(10):1491-7. PubMed ID: 23431033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial vaginosis: current review with indications for asymptomatic therapy.
    Thomason JL; Gelbart SM; Scaglione NJ
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1210-7. PubMed ID: 1951577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recurrent bacterial vaginosis with tinidazole.
    Baylson FA; Nyirjesy P; Weitz MV
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):931-2. PubMed ID: 15516381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
    Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Gardnerella vaginalis as an etiological agent of bacterial vaginosis.
    Baruah FK; Sharma A; Das C; Hazarika NK; Hussain JH
    Iran J Microbiol; 2014 Dec; 6(6):409-14. PubMed ID: 25926959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of isolation and biotypization of Gardnerella vaginalis in diagnosis of bacterial vaginosis.
    Numanović F; Hukić M; Nurkić M; Gegić M; Delibegović Z; Imamović A; Pasić S
    Bosn J Basic Med Sci; 2008 Aug; 8(3):270-6. PubMed ID: 18816262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial.
    McDonald HM; O'Loughlin JA; Vigneswaran R; Jolley PT; Harvey JA; Bof A; McDonald PJ
    Br J Obstet Gynaecol; 1997 Dec; 104(12):1391-7. PubMed ID: 9422018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginosis: Advances in new therapeutic development and microbiome restoration.
    Mohankumar B; Shandil RK; Narayanan S; Krishnan UM
    Microb Pathog; 2022 Jul; 168():105606. PubMed ID: 35644292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis.
    Nagaraja P
    Indian J Med Microbiol; 2008; 26(2):155-7. PubMed ID: 18445953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biotypes and antibiotic resistance patterns of Gardnerella vaginalis strains isolated from healthy women and women with bacterial vaginosis].
    Tosun I; Alpay Karaoğlu S; Ciftçi H; Buruk CK; Aydin F; Kiliç AO; Ertürk M
    Mikrobiyol Bul; 2007 Jan; 41(1):21-7. PubMed ID: 17427549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT.
    Armstrong-Buisseret L; Brittain C; Kai J; David M; Anstey Watkins J; Ozolins M; Jackson L; Abdali Z; Hepburn T; Griffiths F; Montgomery A; Daniels J; Manley A; Dean G; Ross JD
    Health Technol Assess; 2022 Jan; 26(2):1-170. PubMed ID: 35057905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.